Product category:
Nucleic acid sequencing and synthesis
News Release from: Bio-Rad Laboratories
Edited by the Laboratorytalk Editorial
Team on 08 September 2006
Bio-Rad buys Provalis medical
diagnostics business
Bio-Rad Laboratories has completed the purchase of the medical diagnostics business of Provalis for approximately $3 million in cash
Based in the United Kingdom, this business develops, manufactures, and sells point of care diagnostic products for chronic disease management of diabetes and osteoporosis "Point of care testing continues to be of growing importance in the diagnostics area," said Norman Schwartz, Bio-Rad president and CEO
"While this is a relatively small acquisition, it expands our market breadth in the very critical area of diabetes monitoring.".
• Bio-Rad Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
